Modification of the Cp′ ring in the ferrocifen precursor and its influence on the recognition by the estrogen receptor

Tetrahedron Letters

Volumn 44, Issue 13, 2003, Pages 2749-2751

  Kowalski, Konrad ^a,b   Vessières, Anne ^a   Top, Siden ^a   Jaouen, Gérard ^a   Zakrzewski, Janusz ^b  

^a PSL RESEARCH UNIVERSITY   (France)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Estrogen receptor; Ferrocene; Phosphaferrocene; SERM

Indexed keywords

1',2',3',4',5' PENTAMETHYLFERROCENYL; 3',4' DIMETHYLPHOSPHAFERROCENYL; CYCLOPENTADIENE DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FERROCENE DERIVATIVE; HYDROXYBENZOIC ACID DERIVATIVE; IRON COMPLEX; LIGAND; PHOSPHORUS; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN;

EID: 0037463718     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)00284-3     Document Type: Article

References (9)

1. Jordan V.C. Tamoxifen for the Treatment and Prevention of Breast Cancer. 1999;PRR, New York.
2. Top S., Tang J., Vessières A., Carrez D., Provot C., Jaouen G. Chem. Commun. 1996;955-956.
3. Top S., Vessières A., Cabestaing C., Laïos I., Leclercq G., Provot C., Jaouen G. J. Organomet. Chem. 637-639:2001;500-506.
4. Roberts R.M.G., Wells A.S. Inorg. Chim. Acta. 112:1986;171.
5. Roberts R.M.G., Wells A.S. Inorg. Chim. Acta. 120:1986;53.
6. Abd-El-Aziz A.S., Bernardin S. Coord. Chem. Rev. 203:2000;219.
7. Mathey F., De Lauzon G. Organomet. Synth. 1986;259 Elsevier, Amsterdam.
8. Vessières A., Top S., Ismail A.A., Butler I.S., Loüer M., Jaouen G. Biochemistry. 27:1988;6659-6666.
9. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Proc. Natl. Acad. Sci. USA. 93:1996;5925-5930.